Accelerate Diagnostics (AXDX)
(Delayed Data from NSDQ)
$1.78 USD
+0.06 (3.49%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.75 -0.03 (-1.69%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Accelerate Diagnostics (AXDX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$N/A | $N/A | $N/A | N/A% |
Price Target
Accelerate Diagnostics does not have any price target set by analysts.
Analyst Price Targets ()
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for Accelerate Diagnostics. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 2.00 a month ago based on two recommendations. There were one Strong Buy and zero Buy recommendations a month ago.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/AXDX.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/2/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 1 |
Average Target Price | NA |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 81 of 253 |
Current Quarter EPS Est: | -0.47 |